Principe Felipe Research Center

What Principe Felipe Research Center does

The Principe Felipe Research Center (CIPF) is a non-profit biomedical research foundation (Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe, CIF G-46/923421) headquartered in Valencia, Spain, operating as a public research institution under regional government oversight. The organization conducts fundamental and translational biomedical research across three principal disease areas — Cancer, Neuronal Pathologies, and Metabolic Disorders — supplemented by Joint Units covering Rare Diseases, Nanomedicine, Neurological Impairment, Biomedical Imaging, and Developmental Biology. Research is supported by 11 core technology facilities (Electron Microscopy, Advanced Light Microscopy, Flow Cytometry and Cytomics, Genomics and Genetics, Proteomics, Nuclear Magnetic Resonance, Computer Cluster, Animal Models and Comparative Medicine, Screening Platform, and Biomodels), with additional joint infrastructure co-located with the Polytechnic University of Valencia (Nanomedicine Unit UM-02) and the University of Valencia. The research portfolio spans approximately 30+ specialized laboratories with documented outputs including an ERC Advanced Grant 2025 (María Jesús Vicent, polymer therapeutics) and the European Commission's HR Excellence in Research Award.

CIPF's operating model is a hybrid public-foundation structure. Core funding flows from three public sources: the European Commission (ERC, ERDF, H2020, Horizon Europe), the Government of Spain (national PIDs, Plan de Recuperación), and the Generalitat Valenciana (CIDEGENT, ValER). Revenue is supplemented by philanthropic donations (tax-deductible under Spanish Law 49/2002, with up to 80% deduction for individuals) and by fee-based educational services including specialized courses in Bioinformatics, Flow Cytometry, master's programmes, and a Researchers' Programme. Distribution and outreach are driven through scientific publications, international conferences, public lectures, the FBR CIPF Lectures Series, active social media presence across X, Facebook, Instagram, LinkedIn, and YouTube, and structured events targeting researchers, students, healthcare professionals, and the general public. Strategic partnerships include associate membership in EBRAINS (neuroscience infrastructure), scientific exchange with AstraZeneca on DNA damage response therapeutics, and deep collaborative ties with regional academic partners. CIPF does not operate as a commercial enterprise: it has no disclosed revenue, no API, no proprietary commercial product, and no traditional ownership structure.

Name

Principe Felipe Research Center

Legal name

Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe

Website

https://cipf.es

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

The Principe Felipe Research Center (CIPF) is a non-profit biomedical research foundation in Valencia, Spain, conducting translational research in cancer, neuronal pathologies, metabolic disorders, and rare diseases via 11 core facilities, serving academic researchers, clinicians, students, and the general public.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Professional and Management Development Training (611430)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Educational Services (8200)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Biomedical research services
• Genomics and proteomics
• Flow cytometry analysis
• Core research facilities
• Translational medicine research

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Government and Institutional Funding: CIPF receives funding from European Commission, Government of Spain, and Generalitat Valenciana through various research grants and projects
2. Research Grants: Competitive research grants from national and international funding bodies including ERC Advanced Grants, ValER program, and various Spanish national research projects
3. Donations and Philanthropy: Tax-deductible donations from individuals and organizations, with fiscal benefits for donors (up to 80% tax deduction for individuals)
4. Educational Programs and Courses: Fees from specialized courses and workshops including Bioinformatics, Introduction to Flow Cytometry, and Applications of Flow Cytometry

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

CIPF is a non-profit biomedical research foundation that conducts fundamental and translational research in cancer, neuronal pathologies, metabolic disorders, and rare diseases. It operates ten specialized core technology facilities (electron microscopy, flow cytometry, genomics, proteomics, NMR, computational biology, animal models, and screening platforms) that provide advanced research services to internal and external researchers. The center also delivers fee-based educational programs including bioinformatics and flow cytometry training courses, master's degrees, and a researchers' professional development program.

Product overview

The Principe Felipe Research Center (CIPF) is a non-profit biomedical research institution operating as a unified research center rather than a commercial product company. The organization focuses on three main disease research areas: Cancer, Neuronal Pathologies, and Metabolic Disorders. Research is supported by 11 core technology facilities providing advanced services in microscopy, flow cytometry, genomics, proteomics, NMR, computational biology, animal models, and screening platforms. CIPF also offers educational programs including bioinformatics and flow cytometry training courses, master's degrees, and a researchers' program.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Research Programme Multidisciplinary biomedical research programme investigating cancer mechanisms, metabolism, and targeted therapies, including polymer therapeutics, with the goal of advancing treatment options.
• Neuronal Pathologies Research Programme Research programme focused on neurodegenerative diseases, stem cell therapies, cortical circuits, computational biomedicine, tissue regeneration, and vision disorders for academic and clinical partners.
• Metabolic Disorders Research Programme Research programme investigating obesity, diabetes, microbiome interactions, metabolic growth signals, lipotoxicity, fatty liver disease, and molecular neuroendocrinology.
• Electron Microscopy Core Facility Advanced electron microscopy imaging services for biomedical research samples requiring ultrastructural analysis.
• Advanced Light Microscopy Core Facility Confocal and advanced light microscopy imaging services for cellular and tissue analysis, including bioimaging capabilities.
• Flow Cytometry and Cytomics Core Facility Flow cytometry services for cell analysis, cell sorting, and cytomics applications for clinical and biomedical research use.
• Genomics and Genetics Core Facility Genomic sequencing, genetic analysis, and translational genomics services for biomedical research projects.
• Proteomics Core Facility Protein analysis, characterization, and proteomics services for researchers requiring identification and quantification of proteins.
• Nuclear Magnetic Resonance Core Facility NMR spectroscopy services for molecular structure analysis of biomedical samples.
• Computer Cluster Core Facility High-performance computing resources for computational biology, bioinformatics, and large-scale biomedical data analysis.
• Animal Models and Comparative Medicine Core Facility Animal model development and comparative medical research services for preclinical disease study.
• Screening Platform Core Facility High-throughput drug and biomarker screening services for early-stage discovery projects.
• Biomodels Facility Biological model organism development and characterization services for biomedical research.
• Bioinformatics Courses Specialized training courses in bioinformatics and computational biology methods for graduate students and active researchers.
• Flow Cytometry Training Courses Educational workshops covering Introduction to Flow Cytometry and Applications of Flow Cytometry, including teaching materials, exam fees, and diploma; priced at 350€ for graduates and active technicians and 300€ for unemployed persons and students.
• Master's Degree Programme Postgraduate master's degree programme in biomedical research for graduate-level students.
• Researchers' Programme Professional development programme for researchers offered at CIPF.

Quantifiable outcome

• ERC Advanced Grant 2025 awarded to researcher María Jesús Vicent
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• EBRAINScoreStrategic or Co-development PartnerCIPF became an associate member of EBRAINS, a state-of-the-art ecosystem for neuroscience research. This membership enables CIPF to participate in European neuroscience research infrastructure and collaborate with leading neuroscience institutions across Europe.
• AstraZenecacoreStrategic or Co-development PartnerAstraZeneca's Bioscience Department Director and Associate Director delivered lectures at CIPF on targeting DNA damage response in cancer treatment, including development of PARP and ATR inhibitors. The collaboration includes sponsorship of research and joint scientific exchange.
• University of ValenciacoreStrategic or Co-development PartnerStrong collaborative relationship including joint research units (Joint Units), shared educational programs, and co-supervision of PhD students. CIPF hosts joint laboratories and research initiatives with the university.
• Polytechnic University of Valencia (UPV)coreStrategic or Co-development PartnerJoint Nanomedicine Unit (UM-02 Unidad Mixta de Nanomedicina UPV-CIPF) combining expertise in nanotechnology and biomedicine for advanced therapeutic development.
• Barcelona Supercomputing Centre (BSC-CNS)minorStrategic or Co-development PartnerCollaboration through alumni network - Toni Gabaldón, former CIPF postdoc, is now ICREA Research Professor at BSC, demonstrating talent pipeline and ongoing research connections.
• Institute for Research in Biomedicine (IRB Barcelona)minorStrategic or Co-development PartnerCollaboration through alumni network and scientific exchange - Toni Gabaldón holds dual position at BSC and IRB Barcelona.
• Broad Institute of MIT and HarvardminorStrategic or Co-development PartnerCollaboration through alumni network - Fatima Al-Shahrour was a postdoc at CIPF before becoming Computational Biologist at Broad Institute, now leads bioinformatics unit at CNIO.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Barcelona Biomedical Research Park (PRBB): Hosts multiple biomedical research entities in Barcelona including IMIM and others. Provides comparable core facility access, scientific services, and translational research environment to CIPF.
• Centro Nacional de Investigaciones Oncológicas (CNIO): Spain's national cancer research center in Madrid, a public foundation conducting basic and translational oncology research. Fatima Al-Shahrour (CIPF alumna) leads its Bioinformatics Unit, evidencing close ties.
• Centre for Genomic Regulation (CRG): Barcelona-based international biomedical research institute covering genomics, cell biology, and computational biology. Comparable in scale, funding model, and core-facility structure to CIPF.
• Institute for Research in Biomedicine (IRB Barcelona): Spanish biomedical research institute in Barcelona with overlapping focus on cancer, metabolism, and computational biology; already listed as a CIPF collaboration partner via alumni network (Toni Gabaldón dual appointment).
• Centro Nacional de Biotecnología (CNB-CSIC): Spanish national biotechnology research center under CSIC, conducting research in structural biology, molecular biology, immunology, and plant biotechnology. Direct comparable as a Spanish public-sector research center of similar scale.
• Max Planck Institute for Molecular Biomedicine: German Max Planck Society institute focused on molecular and cellular biomedicine, with comparable structure of research groups and core technology platforms supporting vascular biology, cell polarity, and inflammation research.

Broad incumbents

• European Molecular Biology Laboratory (EMBL): Intergovernmental European research organization in molecular life sciences with multiple sites and broader scope than CIPF. Provides a useful comparable for international funding scale, core facility model, and training programs.
• Broad Institute of MIT and Harvard: US biomedical and genomic research institute with strong computational biology and genomics focus. Already linked to CIPF through alumni (Fatima Al-Shahrour was a Computational Biologist there) and comparable in disease-area breadth.
• Institut Pasteur: Historic French non-profit biomedical research foundation with global reach, covering infectious disease, neuroscience, cancer, and developmental biology. Comparable in mission, structure, and non-profit foundation status to CIPF.
• Francis Crick Institute: Large UK biomedical discovery institute with ~1,500 staff and significant public/charitable funding. Comparable in research scope (cancer, neurodegeneration, metabolism) but at substantially larger scale than CIPF.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/cipfciencia
• YouTubeyoutube.com/channel/UCw0K_1FOOkB8MFAj_EdUQow
• Facebookfacebook.com/cipfciencia
• LinkedInlinkedin.com/company/cipf
• Instagraminstagram.com/cipfvalencia

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Principe Felipe Research Center